Renée Benghozi

960 total citations
23 papers, 616 citations indexed

About

Renée Benghozi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Renée Benghozi has authored 23 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Renée Benghozi's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Renée Benghozi is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Renée Benghozi collaborates with scholars based in Switzerland, United States and France. Renée Benghozi's co-authors include Joerg Herrmann, Amir Lerman, Peter K. S. Siegl, Nicola Ferri, Alberto Corsini, Eric J. Niesor, Markus Abt, Pascal Pfister, B Jacotot and David Holmes and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Pharmacology & Therapeutics.

In The Last Decade

Renée Benghozi

23 papers receiving 606 citations

Peers

Countries citing papers authored by Renée Benghozi

Since Specialization

Citations

This map shows the geographic impact of Renée Benghozi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renée Benghozi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renée Benghozi more than expected).

Fields of papers citing papers by Renée Benghozi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renée Benghozi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renée Benghozi. The network helps show where Renée Benghozi may publish in the future.

Co-authorship network of co-authors of Renée Benghozi

This figure shows the co-authorship network connecting the top 25 collaborators of Renée Benghozi. A scholar is included among the top collaborators of Renée Benghozi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renée Benghozi. Renée Benghozi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Red Blood Cell Membrane Cholesterol May Be a Key Regulator of Sickle Cell Disease Microvascular Complications 2022 ·Membranes ·Eric J. Niesor, Élie Nader, Anne Perez, François Lamour, Renée Benghozi, Alan T. Remaley, Swee Lay Thein, Philippe Connes	10
2	Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings 2017 ·Clinical Drug Investigation ·Constance Keyserling, Ronald Barbaras, Renée Benghozi, Jean‐Louis Dasseux	25
3	Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study 2015 ·Clinica Chimica Acta ·Rolf P. Engelberger, Andreas Limacher, Nils Kucher, (unknown), Günther Silbernagel, Renée Benghozi, Dai-Do Do, Torsten Willenberg, Iris Baumgärtner	29
4	Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease 2015 ·Cardiovascular Drugs and Therapy ·Eric J. Niesor, Renée Benghozi, Philippe Amouyel, Keith C. Ferdinand, Gregory G. Schwartz	5
5	Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein 2015 ·Cardiovascular Drugs and Therapy ·Eric J. Niesor, Gregory G. Schwartz, Anne Perez, (unknown), (unknown), (unknown), Renée Benghozi, Markus Abt, David Kallend	53
6	Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome 2015 ·Vascular Pharmacology ·Monica Gomaraschi, Alice Ossoli, Maria Pia Adorni, (unknown), Eric J. Niesor, Fabrizio Veglia, Guido Franceschini, Renée Benghozi, Laura Calabresi	11
7	Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy? 2015 ·Journal of clinical lipidology ·Alaa Othman, Renée Benghozi, Irina Alecu, Wei Yu, Eric J. Niesor, Arnold von Eckardstein, Thorsten Hornemann	33
8	First-in-man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin 2015 ·Journal of Cardiovascular Pharmacology ·Christophe Schmitt, Markus Abt, (unknown), Dorothée Kling, Candice Jamois, Eginhard Schick, Corinne Solier, Renée Benghozi, Jacques Gaudreault	43
9	Potential Signal Transduction Regulation by HDL of the β2-Adrenergic Receptor Pathway. Implications in Selected Pathological Situations 2015 ·Archives of Medical Research ·Eric J. Niesor, Renée Benghozi	8
10	Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis 2015 ·Heart ·Florence Hourcade‐Potelleret, Silvy Laporte, Valerie Lehnert, Paul Delmar, Renée Benghozi, (unknown), (unknown), Patrick Mismetti	10
11	Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity 2013 ·Pharmacology & Therapeutics ·Nicola Ferri, Peter K. S. Siegl, Alberto Corsini, Joerg Herrmann, Amir Lerman, Renée Benghozi	139
12	Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients 2013 ·Journal of clinical lipidology ·Guido Franceschini, Elda Favari, Laura Calabresi, Sara Simonelli, A Bondioli, Maria Pia Adorni, Francesca Zimetti, Monica Gomaraschi, (unknown), Simona Rossomanno, Eric J. Niesor, Franco Bernini, Renée Benghozi	32
13	Xanthophylls, Phytosterols and Pre‐β1‐HDL are Differentially Affected by Fenofibrate and Niacin HDL‐Raising in a Cross‐Over Study 2013 ·Lipids ·Eric J. Niesor, (unknown), (unknown), Gabriela Suchánková, David Kallend, Helena Gylling, Bela F. Asztalos, (unknown), Simona Rossomanno, Markus Abt, W. Sean Davidson, Renée Benghozi	9
14	Frequency of creatine kinase elevation during treatment with fluvastatin 2002 ·The American Journal of Cardiology ·Renée Benghozi, Michele Bortolini, Yan Jia, Jonathan L. Isaacsohn, August J. Troendle, Leonard Gonasun	29
15	Effects of Fluvastatin on Cardiac Events in Renal Transplant Patients: ALERT (Assessment of Lescol(R) in Renal Transplantation) Study Design and Baseline Data 2001 ·European Journal of Cardiovascular Prevention & Rehabilitation ·Hallvard Holdaas, Bengt Fellström, Ingar Holme, G. Nyberg, Per Fauchald, Alan G. Jardine, Carola Grönhagen‐Riska, S. Madsen, H.‐H. Neumayer, Edward Cole, Bart Maes, (unknown), Anders Olsson, Tyler R. Pedersen, Renée Benghozi, Anders Hartmann	59
16	The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease 2001 ·PubMed ·Patrick W. Serruys, Pim J. de Feyter, Renée Benghozi, Paul G. Hugenholtz, Emmanuel Lesaffre	29
17	[Example of a phase IV trial involving several physicians and aiming at answering a scientific question: EOL]. 1997 ·PubMed ·Boissel Jp, (unknown), (unknown), Thiérry Ducruet, (unknown), P Sassano, Renée Benghozi	3
18	Comparison between a bid and a tid regimen: improved compliance with no improved antihypertensive effect 1996 ·European Journal of Clinical Pharmacology ·Jean‐Paul Boissel, (unknown), (unknown), Thiérry Ducruet, (unknown), P Sassano, Renée Benghozi	24
19	Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia 1995 ·The American Journal of Cardiology ·B Jacotot, Renée Benghozi, Pascal Pfister, David Holmes	32
20	The ASPIC trial: Telematics-assisted management of a multicenter clinical trial using a network of laptop personal computers 1989 ·Controlled Clinical Trials ·(unknown), Renée Benghozi, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact